Loss of a-Type Lamin Expression Compromises Nuclear Envelope Integrity Leading to Muscular Dystrophy

Teresa Sullivan(National Cancer Institute), Diana Escalante‐Alcalde(National Cancer Institute), Harshida Bhatt, Miriam R. Anver(National Cancer Institute), Narayan Bhat(National Cancer Institute), Kunio Nagashima(National Cancer Institute), Colin L. Stewart(National Cancer Institute), Brian Burke(University of Calgary)
The Journal of Cell Biology
November 29, 1999
Cited by 1,215Open Access
Full Text

Abstract

The nuclear lamina is a protein meshwork lining the nucleoplasmic face of the inner nuclear membrane and represents an important determinant of interphase nuclear architecture. Its major components are the A- and B-type lamins. Whereas B-type lamins are found in all mammalian cells, A-type lamin expression is developmentally regulated. In the mouse, A-type lamins do not appear until midway through embryonic development, suggesting that these proteins may be involved in the regulation of terminal differentiation. Here we show that mice lacking A-type lamins develop to term with no overt abnormalities. However, their postnatal growth is severely retarded and is characterized by the appearance of muscular dystrophy. This phenotype is associated with ultrastructural perturbations to the nuclear envelope. These include the mislocalization of emerin, an inner nuclear membrane protein, defects in which are implicated in Emery-Dreifuss muscular dystrophy (EDMD), one of the three major X-linked dystrophies. Mice lacking the A-type lamins exhibit tissue-specific alterations to their nuclear envelope integrity and emerin distribution. In skeletal and cardiac muscles, this is manifest as a dystrophic condition related to EDMD.


Related Papers

No related papers found

Powered by citation graph analysis